Very comprehensive. Learned a lot of new things about healthcare across Europe
Consulting Analyst, IMS Health
Market Access Pricing & Reimbursement
Any delay in market access has a direct & significant effect on overall brand value, as this delay is translated into lost time at peak sales. This delay can also deny access to important innovative medicines for patients, their carers and healthcare professionals. New techniques are now being employed by payers to limit access for mature brands, as well as new assets. Therefore market access is a critical success factor for the launch, and life cycle management for most brands in today’s business environment.
The key challenges in market access include understanding who all the key market access stakeholders are at each point in the decision making process, understanding ‘their world’ and what drives them, how to allocate resources and develop meaningful payer value propositions.
GalbraithWight consulting services, tools & processes in market access help companies accurately identify key market access customers & their interrelationships, gain real insight into their specific needs, and develop value propositions which resonate with & meet their needs, resulting in early & sustained access for our Client’s brands.
Our in depth qualitative research methods, conducted in local language to capture the nuances of each interview, are carefully & sensitively deployed with these important market access customer groups, based on many years experience in this field, to ensure accurate results.
Market Access services include:
Market Access, Pricing & Reimbursement Strategy
Senior Payer Insights Research
Pharma Times Interview
Colin Wight is interviewed exclusively by Pharma Times for their 2010 January edition
SMi Pricing and Reimbursement Conference, Munich
Colin Wight chairs and presents at the SMi Pricing & Reimbursement conference held in Munich in October this year.
GalbraithWight's next available public programmes:



